Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

TATYANA FELDMAN

Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology

NPI
1578528089
CMS profile
297826
Location
HACKENSACK, NJ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$19,526.36

25 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

By paying entity

PY2025 · entire year · sorted by reported total

Paying entityAmountRecords
Genmab U.S., Inc. $7,111.41 5
Takeda Pharmaceuticals U.S.A., Inc. $5,294.00 3
ABBVIE INC. $3,807.85 8
Gilead Sciences, Inc. $3,166.21 3
AstraZeneca Pharmaceuticals LP $98.12 3
Kite Pharma, Inc. $48.77 3

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

25 matching records · $19,526.36 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 25 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–25 of 25.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
AstraZeneca Pharmaceuticals LP $60.0012/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261206190436 CMS
AstraZeneca Pharmaceuticals LP $20.2912/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261207157705 CMS
ABBVIE INC. $1.9311/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261201846442 CMS
Takeda Pharmaceuticals U.S.A., Inc. $520.0011/01/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/20261242558696 CMS
Takeda Pharmaceuticals U.S.A., Inc. $1,687.0010/01/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/20261242558700 CMS
ABBVIE INC. $13.1009/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261201846440 CMS
Kite Pharma, Inc. $15.9509/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261212087523 CMS
ABBVIE INC. $6.5808/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261201846438 CMS
Gilead Sciences, Inc. $3,050.0008/08/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261234351398 CMS
Kite Pharma, Inc. $16.3408/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261212087525 CMS
Genmab U.S., Inc. $645.0006/27/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261235928766 CMS
Kite Pharma, Inc. $16.4806/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261212087527 CMS
Gilead Sciences, Inc. $97.8606/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261234402613 CMS
Gilead Sciences, Inc. $18.3506/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261234545631 CMS
Genmab U.S., Inc. $66.6706/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261235928770 CMS
Takeda Pharmaceuticals U.S.A., Inc. $3,087.0006/01/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/20261242558689 CMS
ABBVIE INC. $3.0604/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261201846436 CMS
ABBVIE INC. $3,625.0003/25/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/20261201846434 CMS
ABBVIE INC. $148.9702/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261201846432 CMS
AstraZeneca Pharmaceuticals LP $17.8302/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261207189510 CMS
Genmab U.S., Inc. $124.7401/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261235928761 CMS
ABBVIE INC. $6.3801/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261201846430 CMS
Genmab U.S., Inc. $4,340.0001/30/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/20261235928757 CMS
ABBVIE INC. $2.8301/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261201846428 CMS
Genmab U.S., Inc. $1,935.0001/10/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261235928753 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $31,908.76 33
PY2020 $32,192.94 29
PY2021 $4,890.72 11
PY2022 $30,233.45 17
PY2023 $47,275.84 35
PY2024 $27,128.07 30
PY2025 $19,526.36 25

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
TATYANA FELDMAN, NPI 1578528089. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1578528089.
APA 7
IndustryPayments. (2026). TATYANA FELDMAN, NPI 1578528089 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1578528089
Bluebook
TATYANA FELDMAN, NPI 1578528089, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1578528089.

Source: Centers for Medicare & Medicaid Services, Open Payments.